A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV
Clinical trial NCT03213405 · COMPLETED
Trial details
- NCT number
- NCT03213405
- Sponsor
- Pontificia Universidad Catolica de Chile
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2018-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.